AGP Picks
View all

Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on July 9, 2026

18-Year-Old Marathon Swimmer Maya Merhige Completes North Channel Swim, Her Fifth Oceans Seven Crossing
Hardcore Deconstruction: How Freego USA Inc Builds a Competitive Moat in the US Dirt E-Bike Market
HCC Healthcare Signs Business Combination Agreement with RF Acquisition Corp III to Pursue Nasdaq Listing
Foundation for Sarcoidosis Research Announces New Partnership with Patient Advocate Foundation to Expand Insurance and Disability Support for Sarcoidosis Patients
Singapore launches Diamond & Jewellery Week as record-breaking SIJE heralds new era for the region's jewellery industry
EL TOUR SE ANIMA CON MARCILLA
L’Agence des médicaments du Canada émet une recommandation favorable au remboursement d’EMPAVELI (pegcétacoplan) dans le traitement de la C3G et de la IC-MPGN primaire
Canada’s Drug Agency Issues Positive Reimbursement Recommendation for EMPAVELI® (pegcetacoplan) for the Treatment of C3G and Primary IC-MPGN
Oh!mino Survey Finds GLP-1 Muscle Loss Concerns Drive New Focus on Preserving Muscle While Dieting
Inventiva Announces Completion of the EIB Warrant Restructuring with the Issuance of New EIB Warrants
Inventiva annonce la finalisation de la restructuration des BSA BEI à la suite de l'émission des Nouveaux BSA BEI
Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
Adaptive Biotechnologies to Report Second Quarter 2026 Financial Results on July 29, 2026
Rani Therapeutics Announces Research and Development Collaboration with PegBio to Expand Obesity Pipeline Across Multiple Novel Candidates
Amneal to Report Second Quarter 2026 Results on July 30, 2026
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
Whitestone REIT Shareholders Approve Acquisition by Ares
Nurix Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Global Wellness Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.